Skip to main content
Scheduling

Virtual visit appointments available 7 days a week from 9:00am to 11:00pm. Learn More

COVID-19 Updates

COVID-19 Updates: Get the latest on vaccine information, in-person appointments, virtual visits and more. Learn More

Location

Texas Medical Center

Specialty
Cancer, Blood Disorders
Phone: 832-822-4242

Address

6701 Fannin St., Ste. 1510
Houston, TX 77030

Gengwen Tian, MD, PhD

Instructor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine

Education

School Education Degree Year
Baylor College of Medicine Fellowship Pediatric Hematology/Oncology 2022
Driscoll Children’s Hospital Residency Pediatrics 2019
Baylor College of Medicine PhD Doctor of Philosophy, Immunology 2016
Harbin Medical University Medical School Doctor of Medicine 2011

About

Dr. Gengwen Tian completed her pediatric hematology/oncology fellowship training in 2022. Dr. Tian has had a strong passion for treating patients with malignancies since medical school. With the goal of understanding more about cancer biology and discovering new treatment, Dr. Tian pursued her PhD research in developing new cell therapies against neuroblastoma and lymphoma at the Center for Cell and Gene Therapy Center at Baylor College of Medicine. Dr. Tian started her pediatric hematology/oncology fellowship in 2019 with the goal of becoming a physician-scientist, specializing in the treatment of childhood cancers.

Dr. Tian is interested in treating a variety of childhood malignancies and participating in the development of new therapeutics against childhood cancers. Dr. Tian would like to continue her research on utilizing immune cells to tackle pediatric solid tumors.

Dr. Gengwen Tian is interested in developing new immunotherapies against various childhood cancers. Dr. Tian was involved in multiple research projects, ranging from cancer vaccine development to novel cell therapy against lymphoma and neuroblastoma. Dr. Tian’s work has been published in multiple scientific journals.

Currently, Dr. Tian’s PhD work has progressed to a clinical trial to treat refractory neuroblastoma. Dr. Tian’s goal is to understand how the immune system interacts with cancer cells and how we can train the immune system to better tackle cancer malignancies. Dr. Tian is interested in various tumors, including neuroblastoma, osteosarcoma and Ewing sarcoma.

Board Certifications
American Board of Pediatrics - Pediatrics

Organizations

Organization Name Role
American Academy of Pediatrics (AAP) Member
American Society of Clinical Oncology (ASCO) Member
American Society of Hematology (ASH) Member
American Society of Pediatric Hematology/Oncology (ASPHO) Member
Children’s Oncology Group (COG) Member

Language

English



* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.